TRANSCELLULAR ACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT IN LYMPHOCYTES-T REQUIRES CD4-GP120 BINDING

被引:14
|
作者
MARCUZZI, A
LOWY, I
WEINBERGER, OK
机构
[1] COLUMBIA UNIV,DEPT PHYSIOL & CELLULAR BIOPHYS,NEW YORK,NY 10032
[2] COLUMBIA UNIV,DEPT MED,NEW YORK,NY 10032
关键词
D O I
10.1128/JVI.66.7.4536-4539.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cells expressing human immunodeficiency virus type 1 (HIV-1) tat can transactivate the HIV-1 long terminal repeat (LTR) in cocultured T lymphocytes. In this report, we describe the molecular requirements for transcellular activation of the LTR in Jurkat cells. An analysis with deletion mutants and blocking antibodies demonstrated a requirement for env expression in addition to tat expression for transcellular activation to occur. The results suggest that the transient association of CD4 and gp120 in cocultured cells is required for tat-mediated transcellular activation. The events that follow CD4-gp120 binding in transactivation, however, do not require the gp120-neutralizing domain, in contrast to HIV-mediated fusion and infection. The consequences of this interaction on cellular function are currently under investigation.
引用
收藏
页码:4536 / 4539
页数:4
相关论文
共 50 条
  • [1] TRANSCELLULAR ACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT IN COCULTURED LYMPHOCYTES
    MARCUZZI, A
    WEINBERGER, J
    WEINBERGER, OK
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (07) : 4228 - 4232
  • [2] ACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT BY VACCINIA VIRUS
    STELLRECHT, KA
    SPERBER, K
    POGO, BGT
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (04) : 2051 - 2056
  • [3] INFECTION OF MONOCYTES BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BLOCKED BY INHIBITORS OF CD4-GP120 BINDING, EVEN IN THE PRESENCE OF ENHANCING ANTIBODIES
    PERNO, CF
    BASELER, MW
    BRODER, S
    YARCHOAN, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (04): : 1043 - 1056
  • [4] INVIVO ACTIVATION BY ULTRAVIOLET RAYS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT
    CAVARD, C
    ZIDER, A
    VERNET, M
    BENNOUN, M
    SARAGOSTI, S
    GRIMBER, G
    BRIAND, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (04): : 1369 - 1374
  • [5] Characterization of CD4-gp120 activation intermediates during human immunodeficiency virus type 1 syncytium formation
    Hart, TK
    Truneh, A
    Bugelski, PJ
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (14) : 1305 - 1313
  • [6] CONSTRUCTION OF A BINDING-SITE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 IN RAT CD4
    SCHOCKMEL, GA
    SOMOZA, C
    DAVIS, SJ
    WILLIAMS, AF
    HEALEY, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01): : 301 - 304
  • [7] ACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT BY BTEB, A GC BOX-BINDING TRANSCRIPTION FACTOR
    IMATAKA, H
    MIZUNO, A
    FUJIIKURIYAMA, Y
    HAYAMI, M
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (09) : 825 - 831
  • [8] ANALYSIS OF LONG TERMINAL REPEAT CIRCLE JUNCTIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SMITH, JS
    KIM, SY
    ROTH, MJ
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (12) : 6286 - 6290
  • [9] CHARACTERIZATION OF CONSERVED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 NEUTRALIZATION EPITOPES EXPOSED UPON GP120-CD4 BINDING
    THALI, M
    MOORE, JP
    FURMAN, C
    CHARLES, M
    HO, DD
    ROBINSON, J
    SODROSKI, J
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (07) : 3978 - 3988
  • [10] ANALYSIS OF NATURAL VARIATION IN THE LONG TERMINAL REPEAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    GEELEN, JLMC
    KOKEN, SEC
    VANWAMEL, J
    BOUCHER, CAB
    GOUDSMIT, J
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (03): : 322 - 322